JHP Pharmaceuticals Enters Manufacturing Pact

JHP Pharmaceuticals announced recently that it has entered into a multi-year contract manufacturing agreement with an undisclosed biotechnology company.

JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products, has reached a multi‐year contract manufacturing agreement with an undisclosed biotechnology company. JHP will be responsible for the manufacture and supply of an approved therapy used to treat cancer.

Stuart Hinchen, president and co‐founder of JHP, stated, “We recognize that being selected to produce this crucial drug demonstrates our ability to meet critical marketplace needs. JHP was able to achieve the rigorous timelines required to manufacture this drug through a quality‐driven, experienced staff and a customer‐centric approach. Additionally, our record of cGMP compliance, coupled with our experience in manufacturing site transfers, put us in the position to serve this important customer.”